Combinations of TLR Ligands: A Promising Approach in Cancer Immunotherapy
Toll-like receptors (TLRs), a family of pattern recognition receptors recognizing molecules expressed by pathogens, are typically expressed by immune cells. However, several recent studies revealed functional TLR expression also on tumor cells. Their expressi...
Saved in:
Main Authors: | Saskia Stier, Claudia Maletzki, Ulrike Klier, Michael Linnebacher |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/271246 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reevaluating the Concept of Treating Experimental Tumors with a Mixed Bacterial Vaccine: Coley’s Toxin
by: C. Maletzki, et al.
Published: (2012-01-01) -
pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG
by: Jing Wu, et al.
Published: (2019-01-01) -
Harnessing dendritic cells for pancreatic cancer immunotherapy: a novel promising approach
by: Hui Zeng, et al.
Published: (2025-01-01) -
Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand
by: Tomoko Hayashi, et al.
Published: (2012-01-01) -
The Response of Tissue Mast Cells to TLR3 Ligand Poly(I:C) Treatment
by: Piotr Witczak, et al.
Published: (2020-01-01)